NCT01269827View on ClinicalTrials.gov

Pentoxifylline and Systemic Inflammation in Hemodialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
InflammationEnd-stage Renal DiseaseHemodialysis
Interventions
DRUG

Pentoxifylline

Over a period of 4 months, patients of the study group received one PTX tablet (400 mg) orally once a day (at dinner time)

DRUG

starch tablets

Over a period of 4 months, patients of the control group received one starch tablet orally once a day (at dinner time)

Trial Locations (1)

44320

Hospital de Especialidades, CMNO, IMSS, Guadalajara

All Listed Sponsors
lead

Coordinación de Investigación en Salud, Mexico

OTHER_GOV

NCT01269827 - Pentoxifylline and Systemic Inflammation in Hemodialysis Patients | Biotech Hunter | Biotech Hunter